EMT and Acquisition of Stem Cell-Like Properties Are Involved in Spontaneous Formation of Tumorigenic Hybrids between Lung Cancer and Bone Marrow-Derived Mesenchymal Stem Cells
The most deadly phase in cancer progression is metastatic conversion. Epithelial-to-mesenchymal transition (EMT) is a key process by which cancer cells acquire invasive and metastatic phenotypes. In order to spawn macroscopic metastases, disseminated cancer cells would seem to require self-renewal capability. However, the underlying mechanism defining these processes is poorly understood. One possible mechanism underlying metastasis is fusion between myeloid cells and cancer cells. In this study, we found that spontaneously-formed tumorigenic hybrids between bone marrow-derived mesenchymal stem cells (MSCs) and three different non-small cell lung cancer (NSCLC) cell lines contributed to highly malignant subpopulations with both EMT and stem cell-like properties. Hybrids lost their epithelial morphology and assumed a fibroblast-like appearance. Up-regulation of vimentin, α-smooth muscle actin (α-SMA), and fibronectin, and down-regulation of E-cadherin and pancytokeratin were observed in tumorigenic hybrids. These cells also exhibited increased expression of the stem cell marker prominin-1 (CD133) and over-expression of transcription factors OCT4, Nanog, BMI1, Notch1, ALDH1 as well as Sox2, all genes responsible for regulating and maintaining the stem cell phenotype. In addition, in spontaneously-formed tumorigenic hybrids, increased pneumosphere-forming capacity and tumor-forming ability in NOD/SCID mice were detectable. Thus, cell fusion between lung cancer cells and MSCs provides a nonmutational mechanism that could contribute to aberrant gene expression patterns and give rise to highly malignant subpopulations both capable of EMT and with properties of cancer stem cells (CSCs).
References
[1]
Guo S, Reddy CA, Chao ST, Suh JH, Barnett GH, et al. (2012) Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases. Lung Cancer 77: 389–393. doi: 10.1016/j.lungcan.2012.03.028
[2]
Martínez-Moreno P, Nieto-Cerón S, Torres-Lanzas J, Ruiz-Espejo F, Tovar-Zapata I, et al. (2006) Cholinesterase activity of human lung tumours varies according to their histological classification. Carcinogenesis 27: 429–436. doi: 10.1093/carcin/bgi250
[3]
Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871–890. doi: 10.1016/j.cell.2009.11.007
[4]
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704–715. doi: 10.1016/j.cell.2008.03.027
[5]
Bernards R, Weinberg RA (2002) A progression puzzle. Nature 418: 823. doi: 10.1038/418823a
[6]
Coghlin C, Murray GI (2010) Current and emerging concepts in tumour metastasis. J Pathol 222: 1–15. doi: 10.1002/path.2727
[7]
Powell AE, Anderson EC, Davies PS, Silk AD, Pelz C, et al. (2011) Fusion between Intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming. Cancer Res 71: 1497–1505. doi: 10.1158/0008-5472.can-10-3223
[8]
Ding J, Jin W, Chen C, Shao Z, Wu J (2012) Tumor associated macrophage×cancer cell hybrids may acquire cancer stem cell properties in breast cancer. PLoS One 7: e41942. doi: 10.1371/journal.pone.0041942
[9]
Rappa G, Mercapide J, Lorico A (2012) Spontaneous formation of tumorigenic hybrids between breast cancer and multipotent stromal cells is a source of tumor heterogeneity. Am J Pathol 180: 2504–2515. doi: 10.1016/j.ajpath.2012.02.020
[10]
Wang R, Sun X, Wang CY, Hu P, Chu CY, et al. (2012) Spontaneous cancer-stromal cell fusion as a mechanism of prostate cancer androgen-independent progression. PLoS One 7: e42653. doi: 10.1371/journal.pone.0042653
[11]
Pawelek JM, Chakraborty AK (2008) Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer 8: 377–386. doi: 10.1038/nrc2371
[12]
Dittmar T, Schwitalla S, Seidel J, Haverkampf S, Reith G, et al. (2011) Characterization of hybrid cells derived from spontaneous fusion events between breast epithelial cells exhibiting stem-like characteristics and breast cancer cells. Clin Exp Metastasis 28: 75–90. doi: 10.1007/s10585-010-9359-3
[13]
Bianchi G, Borgonovo G, Pistoia V, Raffaghello L (2011) Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells. Histol Histopathol 26: 941–951.
[14]
Goldstein RH, Reagan MR, Anderson K, Kaplan DL, Rosenblatt M (2010) Human bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis. Cancer Res 70: 10044–10050. doi: 10.1158/0008-5472.can-10-1254
[15]
Chaturvedi P, Gilkes DM, Wong CC, Kshitiz, Luo W, et al. (2013) Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis. J Clin Invest 123: 189–205. doi: 10.1172/jci69244
[16]
Torsvik A, Bjerkvig R (2013) Mesenchymal stem cell signaling in cancer progression. Cancer Treat Rev 39: 180–188. doi: 10.1016/j.ctrv.2012.03.005
[17]
Gottschling S, Granzow M, Kuner R, Jauch A, Herpel E, et al. (2013) Mesenchymal stem cells in non-small cell lung cancer–different from others? Insights from comparative molecular and functional analyses. Lung Cancer 80: 19–29. doi: 10.1016/j.lungcan.2012.12.015
[18]
Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, et al. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557–563. doi: 10.1038/nature06188
[19]
Koh BI, Kang Y (2012) The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cells. EMBO Rep 13: 412–422. doi: 10.1038/embor.2012.41
[20]
Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, et al. (2008) Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15: 504–514. doi: 10.1038/sj.cdd.4402283
[21]
Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, et al. (2009) Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A 106: 16281–16286. doi: 10.1073/pnas.0905653106
[22]
Wang S, Xu ZY, Wang LF, Su W (2013) CD133+ cancer stem cells in lung cancer. Front Biosci 18: 447–453. doi: 10.2741/4113
[23]
Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396–401. doi: 10.1038/nature03128
[24]
Gu P, Harwood LJ, Zhang X, Wylie M, Curry WJ, et al. (2007) Isolation of retinal progenitor and stem cells from the porcine eye. Mol Vis 13: 1045–1057.
[25]
Micalizzi DS, Farabaugh SM, Ford HL (2010) Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 15: 117–134. doi: 10.1007/s10911-010-9178-9
[26]
Guarino M, Rubino B, Ballabio G (2007) The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39: 305–318. doi: 10.1080/00313020701329914
[27]
Zhao JJ, Pan K, Wang W, Chen JG, Wu YH, et al. (2012) The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection. PLoS One 7: e33655. doi: 10.1371/journal.pone.0033655
[28]
Talmadge JE (2011) Immune cell infiltration of primary and metastatic lesions: mechanisms and clinical impact. Semin Cancer Biol 21: 131–138. doi: 10.1016/j.semcancer.2010.12.002
[29]
Zhang BC, Gao J, Wang J, Rao ZG, Wang BC, et al. (2011) Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma. Med Oncol 28: 1447–1452. doi: 10.1007/s12032-010-9638-5
[30]
Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454: 436–444. doi: 10.1038/nature07205
[31]
Lazennec G, Richmond A (2010) Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 16: 133–144. doi: 10.1016/j.molmed.2010.01.003
[32]
Germano G, Allavena P, Mantovani A (2008) Cytokines as a key component of cancer-related inflammation. Cytokine 43: 374–379. doi: 10.1016/j.cyto.2008.07.014
[33]
Davies PS, Powell AE, Swain JR, Wong MH (2009) Inflammation and proliferation act together to mediate intestinal cell fusion. PLoS One 4: e6530. doi: 10.1371/journal.pone.0006530
[34]
Johansson CB, Youssef S, Koleckar K, Holbrook C, Doyonnas R, et al. (2008) Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation. Nat Cell Biol 10: 575–583. doi: 10.1038/ncb1720
[35]
Nygren JM, Liuba K, Breitbach M, Stott S, Thorén L, et al. (2008) Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion. Nat Cell Biol 10: 584–592. doi: 10.1038/ncb1721
[36]
Cogle CR, Theise ND, Fu D, Ucar D, Lee S, et al. (2007) Bone marrow contributes to epithelial cancers in mice and humans as developmental mimicry. Stem Cells 25(8): 1881–1887. doi: 10.1634/stemcells.2007-0163
